HIV (Human Immunodeficiency Virus)
Showing 1 - 25 of >10,000
HIV-1-infection Trial in Madrid (BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato)
Completed
- HIV-1-infection
- BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato
-
Madrid, SpainHospital FUNDACIÓN JIMÉNEZ DÍAZ
Nov 2, 2022
HIV Trial (CAB LA)
Not yet recruiting
- HIV Infections
- CAB LA
- (no location specified)
Nov 21, 2023
HIV Trial (Information, motivation, behavioral skills treatment arm, Information only control arm)
Not yet recruiting
- HIV
- Information, motivation, behavioral skills treatment arm
- Information only control arm
- (no location specified)
Oct 18, 2023
Chikungunya Virus Infection Trial (VLA1553)
Not yet recruiting
- Chikungunya Virus Infection
- VLA1553
- (no location specified)
Aug 31, 2023
Gut Microbiome in People Living With HIV and HBV
Not yet recruiting
- Human Immunodeficiency Virus
- +2 more
- (no location specified)
Nov 8, 2023
Human Immunodeficiency Virus Infection, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)
Not yet recruiting
- Human Immunodeficiency Virus Infection
- +2 more
- Patient Participation Form
- (no location specified)
Mar 3, 2023
HIV, Non-Alcoholic Fatty Liver Disease, Metabolic-Associated Steatotic Liver Disease Trial in Nashville (Prebiotic, Probiotic)
Not yet recruiting
- HIV
- +2 more
- Prebiotic
- Probiotic
-
Nashville, TennesseeVanderbilt University Medical Center
Oct 30, 2023
Tuberculosis, Human Immunodeficiency Virus Trial in Makasar (Active Hexoses Correlated Compound)
Completed
- Tuberculosis
- Human Immunodeficiency Virus
- Active Hexoses Correlated Compound
-
Makasar, South Sulawesi, IndonesiaLabuang Baji General Hospital
Oct 27, 2021
HIV Trial (TM HIV, TM HL)
Not yet recruiting
- HIV Infections
- TM HIV
- TM HL
- (no location specified)
Oct 12, 2023
HIV (Human Immunodeficiency Virus) Trial in Geita, Kagera (Conditional Cash Transfer)
Recruiting
- HIV (Human Immunodeficiency Virus)
- Conditional Cash Transfer
-
Geita, Tanzania
- +1 more
Aug 10, 2022
HIV (Human Immunodeficiency Virus) Trial in Bukoba, Geita (Enhanced Adherence Counseling and Conditional Cash Transfers)
Not yet recruiting
- HIV (Human Immunodeficiency Virus)
- Enhanced Adherence Counseling and Conditional Cash Transfers
-
Bukoba, Tanzania
- +1 more
Aug 10, 2022
HIV, Aging Trial in Winston-Salem (Customized activity plan, Customized nutrition plan)
Not yet recruiting
- HIV
- Aging
- Customized activity plan
- Customized nutrition plan
-
Winston-Salem, North CarolinaAtrium Health Wake Forest Baptist
May 12, 2023
Human Immuno-deficiency Virus (HIV) Disease Trial (Budigalimab, Placebo for Budigalimab, ABBV-382)
Not yet recruiting
- Human Immuno-deficiency Virus (HIV) Disease
- Budigalimab
- +3 more
- (no location specified)
Sep 5, 2023
Alcohol Use Disorder, Human Immunodeficiency Virus Trial in Chicago (10 day prebiotic consumption)
Not yet recruiting
- Alcohol Use Disorder
- Human Immunodeficiency Virus
- 10 day prebiotic consumption
-
Chicago, IllinoisAli Keshavarzian
Nov 14, 2023
Human Immunodeficiency Virus, HIV Trial (Islatravir, Placebo)
Not yet recruiting
- Human Immunodeficiency Virus
- HIV
- Islatravir
- Placebo
- (no location specified)
Oct 13, 2022
HIV Trial in Washington (Antiretroviral Therapy Interruption(ATI))
Enrolling by invitation
- HIV
- Antiretroviral Therapy Interruption(ATI)
-
Washington, District of Columbia
- +1 more
Sep 12, 2022
Human Immunodeficiency Virus Trial in Chicago (brentuximab vedotin, Placebo, ART)
Recruiting
- Human Immunodeficiency Virus
- brentuximab vedotin
- +2 more
-
Chicago, IllinoisUniversity of Illinois at Chicago
Jul 29, 2022
Human Immunodeficiency Virus (HIV) Trial (Doravirine, Tenofovir, Lamivudine, ATRIPLA™, Placebo)
Active, not recruiting
- Human Immunodeficiency Virus (HIV)
- Doravirine, Tenofovir, Lamivudine
- +2 more
- (no location specified)
Sep 1, 2022
Human Immunodeficiency Virus, Smoking Cessation, Smoking, Tobacco Trial in Boston, Chennai (Varenicline, Positively Smoke Free
Not yet recruiting
- Human Immunodeficiency Virus
- +2 more
- Varenicline
- +2 more
-
Boston, Massachusetts
- +1 more
Mar 13, 2023
Human Immunodeficiency Virus Trial run by the CC (Placebo, Pembrolizumab)
Recruiting
- Human Immunodeficiency Virus
- Placebo
- Pembrolizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
HIV I Infection Trial in United States (VIR-1111, Placebo)
Active, not recruiting
- HIV I Infection
- VIR-1111
- Placebo
-
Miami, Florida
- +3 more
Jul 22, 2022
HIV Infection, Combined Antiretroviral Therapy Trial in Hangzhou
Recruiting
- HIV Infection
- Combined Antiretroviral Therapy
-
Hangzhou, Zhejiang, ChinaZhikai Wan
Aug 30, 2023